Journal of Cancer Prevention

eISSN 2288-3657
pISSN 2288-3649

Evaluation of ER, PR, HER2, and Ki-67 using immunohistochemistry (n = 41)
Variables Frequency
ER
Positive 38 (92.7)
Negative 3 (7.3)
PR
Positive 27 (65.9)
Negative 14 (34.1)
HER2
Positive 8 (19.5)
Negative 33 (80.5)
Ki-67
High 25 (61.0)
Low 16 (39.0)

Values are presented as number (%). ER, estrogen receptor; PR, progesterone receptor; HER2, human epidermal growth factor receptor 2.

J Cancer Prev 2023;28:64~74 https://doi.org/10.15430/JCP.2023.28.2.64
© J Cancer Prev
© Korean Society of Cancer Prevention. / Powered by INFOrang Co., Ltd